Abstract
1. Following intravenous bolus injections or brief infusions in healthy volunteers, plasma concentrations of doxapram declined in a multi-exponential fashion. The mean half-life from 4-12 h was 3.4 h (range 2.4-4.1h), the mean apparent volume of distribution was 1.5 1 kg-1 and the whole body clearance was 370 ml min-1. 2. Enteric-coated capsules of doxapram base were absorbed rapidly after an initial delay, and the systemic availability was about 60%. 3. Doxapram is extensively metabolized and less than 5% of an i.v. dose was excreted unchanged in the urine in 24 h. A metabolite (AHR 5955) was present in plasma in amounts comparable to the parent compound and had a similar half-life. 4. The disposition of doxapram appears to be similar in healthy volunteers and patients with respiratory failure. 5. The previously held belief that plasma concentrations fall rapidly when an infusion is stopped is only true following short duration infusions. The pharmacokinetic properties of doxapram are such that steady-state plasma concentrations will not be achieved for many hours with the recommended constant rate infusion régime.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aiache J. M., Aiache S., Jeanneret A., Cornat F. Méthodes d'évaluation biopharmaceutique des gélules entériques: application aux gélules "Enterocaps". Boll Chim Farm. 1975 Nov;114(11):636–650. [PubMed] [Google Scholar]
- BRUCE R. B., PITTS J. E., PINCHBECK F., NEWMAN J. EXCRETION, DISTRIBUTION, AND METABOLISM OF DOXAPRAM HYDROCHLORIDE. J Med Chem. 1965 Mar;8:157–164. doi: 10.1021/jm00326a004. [DOI] [PubMed] [Google Scholar]
- Gawley T. H., Dundee J. W., Gupta P. K., Jones C. J. Role of doxapram in reducing pulmonary complications after major surgery. Br Med J. 1976 Jan 17;1(6002):122–124. doi: 10.1136/bmj.1.6002.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gupta P. K., Moore J. The use of doxapram in the newborn. J Obstet Gynaecol Br Commonw. 1973 Nov;80(11):1002–1006. doi: 10.1111/j.1471-0528.1973.tb02965.x. [DOI] [PubMed] [Google Scholar]
- Jones C. J., Luscombe D. K., Nicholls P. J. Proceedings: Absorption, distribution and excretion of doxapram hydrochloride in the rat. J Pharm Pharmacol. 1973 Dec;25(Suppl):139P–1140. [PubMed] [Google Scholar]
- Riordan J. F., Sillett R. W., McNicol M. W. A controlled trail of doxapram in acute respiratory failure. Br J Dis Chest. 1975 Jan;69(1):57–62. doi: 10.1016/0007-0971(75)90056-x. [DOI] [PubMed] [Google Scholar]
- Robson R. H., Prescott L. F. Rapid gas--liquid chromatographic estimation of doxapram in plasma. J Chromatogr. 1977 Sep 1;143(5):527–529. [PubMed] [Google Scholar]